Status:
COMPLETED
Diagnostic Efficacy and Prognostic Value of 18F-FDG PET/CT (MR) in Pediatric Solid Blastoma
Lead Sponsor:
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Conditions:
18F-FDG
Neuroblastoma
Eligibility:
All Genders
Up to 18 years
Brief Summary
the primary histologic origin of extracranial solid tumors in children is malignant embryonic cells, including Neuroblastoma (NB) , Hepatoblastoma(HB), and kidney, wilms' tumor(WT). Their main clinica...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- age \< 18 years,
- have pathological results or definite clinical diagnosis as the gold standard.
- Exclusion Criteria：
- had surgery or chemotherapy before imaging,
- accompanying other tumors,
- diabetic patients or patients with fasting blood glucose ≥ 200 mg/dL.
Exclusion
Key Trial Info
Start Date :
July 30 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 30 2023
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06190574
Start Date
July 30 2021
End Date
November 30 2023
Last Update
March 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
China, Hubei Province
Wuhan, Hubei, China, 430022